HerrstedtJ , GrunbergS , RolskiJ , etal : Phase Ⅲ resultsfothenovel Neurokinin-1 ( NK-1 ) receptorantagonist , casopitant : Singleoral dosingregimenforchemotherapy-ind CINV ) inpatients ( Pts ) receivinghighlyemetogenicchemoth HEC ) .Abstr9549 ) .Grunberg ......